These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23480151)

  • 1. AMPA receptors as a molecular target in epilepsy therapy.
    Rogawski MA
    Acta Neurol Scand Suppl; 2013; (197):9-18. PubMed ID: 23480151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors.
    Hanada T
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32197322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPA receptors in epilepsy and as targets for antiepileptic drugs.
    Rogawski MA; Donevan SD
    Adv Neurol; 1999; 79():947-63. PubMed ID: 10514878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist.
    Rogawski MA; Hanada T
    Acta Neurol Scand Suppl; 2013; (197):19-24. PubMed ID: 23480152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular insights into the role of AMPA receptors in the synaptic plasticity, pathogenesis and treatment of epilepsy: therapeutic potentials of perampanel and antisense oligonucleotide (ASO) technology.
    Charsouei S; Jabalameli MR; Karimi-Moghadam A
    Acta Neurol Belg; 2020 Jun; 120(3):531-544. PubMed ID: 32152997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
    Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
    J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.
    Di Bonaventura C; Labate A; Maschio M; Meletti S; Russo E
    Expert Opin Pharmacother; 2017 Nov; 18(16):1751-1764. PubMed ID: 29023170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.
    Löscher W
    Prog Neurobiol; 1998 Apr; 54(6):721-41. PubMed ID: 9560847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPA Receptors as Therapeutic Targets for Neurological Disorders.
    Lee K; Goodman L; Fourie C; Schenk S; Leitch B; Montgomery JM
    Adv Protein Chem Struct Biol; 2016; 103():203-61. PubMed ID: 26920691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery and development of perampanel for the treatment of epilepsy.
    Hanada T
    Expert Opin Drug Discov; 2014 Apr; 9(4):449-58. PubMed ID: 24559052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
    Radenovic L; Selakovic V
    Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abolishing spontaneous epileptiform activity in human brain tissue through AMPA receptor inhibition.
    Wright SK; Wilson MA; Walsh R; Lo WB; Mundil N; Agrawal S; Philip S; Seri S; Greenhill SD; Woodhall GL
    Ann Clin Transl Neurol; 2020 Jun; 7(6):883-890. PubMed ID: 32426918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perampanel (Fycompa) for epilepsy.
    Med Lett Drugs Ther; 2014 Feb; 56(1435):9-10. PubMed ID: 24662975
    [No Abstract]   [Full Text] [Related]  

  • 17. The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia.
    Brito da Silva A; Pennifold J; Henley B; Chatterjee K; Bateman D; Whittaker RW; Joshi A; Kumar H; Nicholson C; Baker MR; Greenhill SD; Walsh R; Seri S; Jones RSG; Woodhall GL; Cunningham MO
    Epilepsia Open; 2022 Sep; 7(3):488-495. PubMed ID: 34653311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy.
    Citraro R; Russo E; Gratteri S; Di Paola ED; Ibbadu GF; Curinga C; Gitto R; Chimirri A; Donato G; De Sarro G
    Neuropharmacology; 2006 Nov; 51(6):1058-67. PubMed ID: 16901515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel therapeutic approach for treatment of catamenial epilepsy.
    Joshi S; Sun H; Rajasekaran K; Williamson J; Perez-Reyes E; Kapur J
    Neurobiol Dis; 2018 Mar; 111():127-137. PubMed ID: 29274741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src/CK2/PTEN-Mediated GluN2B and CREB Dephosphorylations Regulate the Responsiveness to AMPA Receptor Antagonists in Chronic Epilepsy Rats.
    Kim JE; Lee DS; Park H; Kang TC
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.